chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient in waiting area post vaccination reports dizziness, generalized weakness, delayed speech, and left leg weakness. Helped to laying position. Blood pressure of 158/110 noted. Patient oriented and able to follow commands. Provider notified. Transported to ER.
Fingers were numb beginning about 17 to 20 hours after injection.  Ran temp of 103.7 for 2 days now it's running around 100.5 and slightly growing down with Tylenol and ibuprofen. Body aches including ovary pain and cramps with lower back pain.
Approximately 24 hours post vax, pt developed an injection site reaction characterized by redness and induration. The pt also developed a fever of 101F that lasted for 1-2 days, then a fever of 99-100F. She also experienced malaise, shortness of breath, a choking sensation and chest tightness. The reporter stated that the injection site reaction had resolved, but the other events are "ongoing to a lesser degree." The MD noted that these events "may be related" to an injection of MMR that the pt recvd 1 wk earlier. A copy of this report has been forwarded to Merck, manufacturer of MMR.
Hurting of left arm for 48 hours/Achy left arm; Swelling of left side of face; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurting of left arm for 48 hours/Achy left arm) and SWELLING FACE (Swelling of left side of face) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (Hurting of left arm for 48 hours/Achy left arm) and SWELLING FACE (Swelling of left side of face). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Hurting of left arm for 48 hours/Achy left arm) outcome was unknown and SWELLING FACE (Swelling of left side of face) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Within 6-8 h after receiving the vaccine, I noticed progressive pain on my left shoulder and upper arm.  I could not sleep on my left side. At 22 h after the vaccine I could not abduct my arm due to the local pain, became prostrated (had to lay down all day), lost appetite (only ate 2 cookies all day) and became very fatigued (went to sleep at night at 7 pm instead of my 10 pm regular sleeping time). I measured my temperature twice and it was 37.5 C. I didn't take antiinflammatory nor analgesic medicine.  At 48 h after the vaccine, I was already 80% better, and at 72 h  has back to normal. I had short-lived (2-3 days) COVID-19 symptoms in March 2020 (anosmia, diarrhea, anorexia) and high titers of anti-SARS-CoV-2 serum IgG in May and October (I did the latter was part of an experiment to evaluate the duration of antibody persistence. I am fully vaccinated and this was by far my most severe vaccinal reaction.
Patient's heart felt racing, started to get clammy and flushed 10 minutes after receiving the vaccine.
Devel Herpes Zoster post vax 12/20. Rash included right eye.
Patient came in for Covid Vaccination.  Patient reported receiving her first dose from Clinic 03/09/21.  Patient was asked why she was receiving her second dose here instead. She reported they had not called her for her second dose but she wanted to go ahead and get it done.  After speaking to the patient and seeing her appointment logged in her personal calendar for March 9th she was administered her second dose of Moderna Covid 19 vaccine (she misplaced her vaccination card). When we tried to bill it as a second vaccine it showed no record of a first immunization.  We checked and it showed the patient had received Covid 19 Moderna vaccine at Clinic 04/14/21 entered into the system as part of a batch load.  I then called the patient to see if she did get the vaccine March 9th or April 14th.  The patient was adamant that it was March 9th.  I called her primary physician April 19th to verify.  Upon speaking with the physician, she reported that the patient has memory issues and she did receive her first dose April 14th not March 9th.  I then spoke with the patient and she then admitted to having memory issues and wanted me to add that note to her patient record.  I asked her if she was feeling ok, having any adverse side effects, or any issues at all on April 19th.   The patient said no to all questions and said she was feeling fine.  Her physician was informed of what happened and they were going to contact a family member to let them know and to urge them to help her with her medical appointments from now on. Her physician said she planned to administer a third dose and will contact the patient to set up an appointment.
Febrile seizure 9/7 after shots given. That day went out of town and went to ER. Was behind on shots and going out of the country.
R upper and lower arm very swollen and red. Painful. Was treated per PCP with antibiotics and BENADRYL. PNEUMOVAX given in R arm.
pt recvd vax 5JAN94 & 2AM on 7JAN94 had fever of 104.6 other s/s was runney nose; 9AM temp was 103.3; mom described as limp as a dish rag;
Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot number: EW0176) via intramuscular route of administration in the left arm on 29Apr2021 at 14:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and hypertension. The patient was allergic to fish (walleye). Concomitant medications included ZOLOFT, Omeprazole, Lisinopril-Hydrochlorothiazide, and Atorvastatin, all for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 05:00, the patient experienced moderate pain at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain at injection site was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Initial report received from a health care professional on 06 December 2010. A 76-year-old female patient received on 15 November 2010 a left deltoid intramuscular injection of FLUZONE SV 2010-2011, lot number U3728AA. The patient had an allergy to penicillin, codeine and CELEBREX. She had a history of H. pylori, left hemi-stroke, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), mild diverticulosis, increased blood pressure and restless leg syndrome. The patient's concomitant medications included PLAVIX, ZYRTEC, METAMUCIL, ASA, calcium and LOTENSIN. She denied any illness at the time of vaccination. On 16 November 2010, the patient, within 24 hours of the vaccine, developed urticaria and a full body red blotchy rash. She was seen by her physician and treated with prednisone. The duration of the rash was unknown since the patient did not follow-up with the requested phone call to the physician's office. The outcome was reported as unknown. Documents held by sender: None.
Moderna COVID-19 Vaccine EUA  Around 6pm same day as my shot I started feeling chills, tiredness and joint aches.   I slept very restless and took some Ibuprofen around 1am,  drank a bottle of water, had a snack because I was suddenly hungry and went back to sleep.
it's very hot to the touch; discomfort when breathing, not hard to breath but discomfort; shooting pain in the head; pain; very itchy/unbelievably itchy and that is a very large area; swollen under and around the injection site; the first days was very tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (it's very hot to the touch), DYSPNEA (discomfort when breathing, not hard to breath but discomfort), PAIN (shooting pain in the head), VACCINATION SITE PAIN (pain) and VACCINATION SITE PRURITUS (very itchy/unbelievably itchy and that is a very large area) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (it's very hot to the touch), DYSPNEA (discomfort when breathing, not hard to breath but discomfort), PAIN (shooting pain in the head), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (very itchy/unbelievably itchy and that is a very large area), VACCINATION SITE SWELLING (swollen under and around the injection site), FATIGUE (the first days was very tired) and CHILLS (chills). At the time of the report, VACCINATION SITE WARMTH (it's very hot to the touch), DYSPNEA (discomfort when breathing, not hard to breath but discomfort), PAIN (shooting pain in the head), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (very itchy/unbelievably itchy and that is a very large area), FATIGUE (the first days was very tired) and CHILLS (chills) outcome was unknown and VACCINATION SITE SWELLING (swollen under and around the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder; tender/very sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tender/very sore injection site) and ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (tender/very sore injection site). On 16-Feb-2021, the patient experienced ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder). At the time of the report, VACCINATION SITE PAIN (tender/very sore injection site) and ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  patient took  two doses of Ibuprofen for Treatment.     Reporter did not allow further contact
1/14/21 around 9am ,I felt a little weak, chills, watery eyes and runny nose.  Temp was 100.  I took tylenol at 6am for a headache.  The temp continued to increase and the highest was 103.9 on January 14th.  I also developed significant pain in my muscles and joints, along with weakness, and fatigue.  January 15 the, highest temp was 102.5 no watery eyes or runny nose.  Muscle pain and weakness continues but less intense.  January 16th, as of this time temp 100 and muscle weakness with very little pain.  Fatigue continues.
t102 (forehead strip) @ MD office; hives all over body onset 22AUG PM; still has everywhere @ 930AM 23AUG; MD prescribed APAP & Atarax; mom used DPH 22AUG;
Dizziness, had it before shot, but know worse.  Started after getting shot and has happened intermittently since.
Case number PHEH2014US000913 is an initial spontaneous report received from a medical assistant on 08 Jan 2014. This report refers to a female patient whose age was not reported. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1308801) subcutaneously on 06 Jan 2014. It was reported that her vaccination site had redness on the same date. The event outcome was not reported.
Headache, Myalgia, Arthralgia & NauseaVomiting Narrative:  referred to PCP for cont. body ache  Other Relevant History:
Vomiting, Fever, Diarrhea, Nausea, Vertigo, Convulsions, Extreme Fatigue, Disorientation, Extreme Blurred Vision, Problems With Night vision, Extreme Chest Pain, Short of Breath, Extra Sleeping, Decreased Productivity, Confusion, Getting Lost Abnormally, Decreased to NO appetite
Patient stated he didn't feel well and he was lightheaded, instructed patient to place head in between legs and applied a cool compress to the back of the neck. patient then vomited, provided water. Obtained pulse and blood pressure readings. 1125: Pulse:83, BP: 98/78; 1130: Pulse:72, BP: 115/82. instructed patient to wait 5 minutes in lobby to ensure safety before leaving facility.  Patient also received a TB test on the opposite arm at prior to administering flu vaccine.
26-year-old female with past medical history of asthma and anxiety, and syncopal episode after her first Covid vaccination, presents to the emergency department after syncopal episode after her second Covid vaccination.  Patient states she received her shot, and about 45 seconds later started feeling similar to the way she felt during the first syncopal episode.  She started having tunnel vision, and her mom who is with her this time, notes that she was getting more pale.  Mom notes that patient was talking about what she was feeling and was slowing down, until she passed out for about 30 seconds.  During her LOC, she was shrugging her shoulders repeatedly, and after she awoke, she returned to her baseline mental status after about a minute or 2.  As she was returning to her baseline mental status, she was talking about how she was feeling and it was appropriate.  No urinary incontinence or tongue biting.  Denies any recent chest pain, shortness of breath, other episodes of lightheadedness or syncope.  She is not had syncopal episodes after shots before.  After her last injection, she had a syncopal episode and fell flat on her face, thus had a CT head.  At the time her CT head is negative, she had a D-dimer that was also negative.  Her labs at the time were notable for hypokalemia 3.3, and in preparation for that she states she has been eating a lot of bananas this week.  At this time she does not want any lab work, and feels as if this was a similar vasovagal episode similar to last time.  syncopal episode right after a COVID vax. Same thing happened with the first dose. Prior to passing out felt sweaty, lightheaded, body tingling then passed out. Didn't fall this time as she was expecting it. Never had fear of needles before. No abd pain, back pain, chest pain. No h/o PE, DVT, OCPs, calf pain, SOB. No cough, SOB, palpit, diaph, chest pain/pressure, headache. No abd pain, no back pain, no vomit, no diar. No urinary complaints. No rash. No numb/weakness. No URI Sx. Mom noted a few shoulder twitches but not GTC type symptoms.      rapid response called, pt went to emergency department
10:05 Patient given 0.5cc Fluarix flu vaccine IM left deltoid without incident. 10:20 Complaints of rash and pruritus upper chest, neck and facial area; face flushed. Given Benadryl 25mg PO 2 times and reported to doctor. Advised contact personal MD or present to clinic for Solumedrol PRX. 12/1 No rash/pruritus reported.
15yo Female presented for her first dose of Pfizer. NO h/o anaphylaxis or seizures, or other medical history reported. Pt felt well prior to vaccination. Post vaccination (<1 minute) she lost consciousness. <1 minute post vaccine patient started to fall from chair. She was assisted to the ground by RN, no trauma to the head. No pulse was present initially, EMS was activated immediately. BP readings were initially low and started increasing with the 5-minute intervals. EMS arrived and took over care at 12:55. With EMS present she had a second episode and fell to the ground unassisted. She was taken to hospital, mother present at scene.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient hospitalized for recurrent urinary tract infection and altered mental status. Received antimicrobials and supportive care.
B-cell non-Hodgkin's lymphoma; booster; MARKETING PROGRAM NAME IS NOT AVAILABLE  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 21K-163-4148979-00 (AbbVie).  A 77 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 17Aug2021 (Batch/Lot number: unknown) at the age of 77 years as dose 3(booster), single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for ankylosing spondylitis. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), administration date: 26Jan2021, when the patient was 77 years old, for Covid-19 immunization; Bnt162b2 (Dose: 2), administration date: 23Feb2021, for Covid-19 immunization, reaction(s): "Breast Cancer"; Bnt162b2 (Dose: 2), administration date: 23Feb2021, for COVID-19 immunization, reaction(s): "Lung Cancer". The following information was reported: B-CELL LYMPHOMA (medically significant) with onset 03Nov2021, outcome "not recovered", described as "B-cell non-Hodgkin's lymphoma"; IMMUNISATION (medically significant) with onset 17Aug2021, outcome "unknown", described as "booster".  Additional Information:Causality for Humira (adalimumab) The reporter's causality for the event of BASAL CELL NON HODGKIN'S LYMPHOMA was not provided. AbbVie's opinion is that the events of BASAL CELL NON HODGKIN'S LYMPHOMA are not assessable.Causality for PFIZER BIONTECH COVID-19 VACCINE(TOZINAMERAN) The reporter's causality for the event of BASAL CELL NON HODGKIN'S LYMPHOMA was not reported. Action taken was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information the reported event B cell lymphoma not related to suspect product BNT162B2 due to long temporal association.
Information has been received from a health professional concerning a patient who was vaccinated with a dose of MMRII. Subsequently,2-3 days after vaccination, the patient developed a fever and  rash. The patient sought unspecified medical attention. Additional information has been requested.
7 days after injection I have a red raised (at times itchy) rash at the injection site.  I also have tenderness and irritation in my under arm and armpit.  But I don't have a rash in those areas.  I am filling this out as of 2/22/21 and I still have the red raised rash and tenderness in my under arm and armpit.
Bleeding from injection site at time of injection.  Next day, sever bruising, swelling and pain.  4 weeks later, still bruised and more painful!   The pain is now radiating down my arm.  I thought it would get better over time, but it has not.  Now I am concerned about getting the second vaccine.  I am also experiencing fatigue and other muscle pain.
Information has been received from a physician concerning an otherwise healthy 32-year-old female patient who in 1995 or 1996 was vaccinated with a first dose of VARVAX vaccine. Prior to vaccination, the patient developed aseptic meningitis. Subsequently the patient received the second dose of VARVAX vaccine and approximately 4-5 weeks later developed aseptic meningitis. On 27-FEB-2000 the patient was admitted to the hospital for her experience. A lumbar puncture was performed adn the CSF Wbc's were 754. There had been '5 more episodes of aseptic meningitis where the patient's CSF paraneters were clearly indicative of viral meningitis. The patient is being treated with acyclovir 10 mg. It was noted that this is the patient's fifth hospitalization. Additionally, it was reported that the patient experienced the normal symptoms such as photophobia, fever, etc. with each episode and recovered after each incident without residual. The physician belives that it may be herpes simplex meningitis or that it may be secondary to the VARVAX vaccine. On 29-FEB-2000, a CSF specimen was to have been sent to university for PCR analysis. Additional information has been requested.
This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hep B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injections of Engerix B on 8/30/93 (1200A2) adn 5/9/94 (1360B2). He also received injections of diphtheria and tetanus toxoids and pertussis vaccine (6/22/93 and 8/30/93), combination diphtheria and tetanus toxoids and pertussis vaccine/haemophilus influenzae type B conjugte vaccine (tetramune 10/20/94, and Haemophilus influenzae type B conjugate vacine on 6/22/93 and 8/30/93. The subject's attorney alleged that the subject "suffered devastating injuries through mercury toxicity and associted complications and sequelae and the aggravation of other condition directly through exposure, via an IM injection of mercury." The subject' attorney further alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Severe chills, shortness of breath approx 13 hours after vaccination. Subsequent headache and body ache.
Received Gardasil 12/6/07. Woke up 12/9/07 with hand, fingers and toes swollen and itching. Cheek bones itching as well. Symptoms resolving 12/11/07
The patient was administered a vaccine past the beyond use date. The dose was administered on 6/8/21. The beyond use date was 5/13/2021. The vaccine was properly stored in the fridge, punctured the morning of 6/8/21, and administered within the recommended 12 hour window. No adverse effects have been reported from the patient.